COVID-19: A review of therapeutic strategies and vaccine candidates.


Journal

Clinical immunology (Orlando, Fla.)
ISSN: 1521-7035
Titre abrégé: Clin Immunol
Pays: United States
ID NLM: 100883537

Informations de publication

Date de publication:
01 2021
Historique:
received: 13 11 2020
accepted: 13 11 2020
pubmed: 21 11 2020
medline: 29 1 2021
entrez: 20 11 2020
Statut: ppublish

Résumé

The world is engulfed by one of the most widespread and significant public health crises in decades as COVID-19 has become among the leading causes of death internationally. The novel SARS-CoV-2 coronavirus which causes COVID-19 has unified the scientific community in search of therapeutic and preventative solutions. The top priorities at the moment are twofold: first, to repurpose already-approved pharmacologic agents or develop novel therapies to reduce the morbidity and mortality associated with the ever-spreading virus. Secondly, the scientific and larger pharmaceutical community have been tasked with the development, testing, and production of a safe and effective vaccine as a longer-term solution to prevent further spread and recurrence throughout the populace. The purpose of this article is to review the most up-to-date published data regarding both the leading pharmacological therapies undergoing clinical trials and vaccine candidates in development to stem the threat of COVID-19.

Identifiants

pubmed: 33217545
pii: S1521-6616(20)30794-4
doi: 10.1016/j.clim.2020.108634
pmc: PMC7670907
pii:
doi:

Substances chimiques

Adrenal Cortex Hormones 0
Antiviral Agents 0
COVID-19 Vaccines 0
Complement Inactivating Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

108634

Subventions

Organisme : NIAMS NIH HHS
ID : R61 AR078075
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR076440
Pays : United States
Organisme : NIAMS NIH HHS
ID : K08 AR070891
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Lancet. 2020 Sep 26;396(10255):887-897
pubmed: 32896291
Lancet. 2020 Jun 13;395(10240):1845-1854
pubmed: 32450106
Clin Microbiol Infect. 2020 Oct;26(10):1426-1427
pubmed: 32447049
Mayo Clin Proc. 2020 Sep;95(9):1888-1897
pubmed: 32861333
Science. 2020 Aug 21;369(6506):1010-1014
pubmed: 32540901
Crit Care. 2020 May 6;24(1):198
pubmed: 32375845
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
Infect Genet Evol. 2020 Sep;83:104351
pubmed: 32387564
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
JAMA. 2020 Sep 8;324(10):951-960
pubmed: 32789505
Clin Immunol. 2020 Jun;215:108450
pubmed: 32360516
Drugs. 2014 Oct;74(15):1731-45
pubmed: 25204470
Curr Opin Biotechnol. 1999 Oct;10(5):440-7
pubmed: 10508634
N Engl J Med. 2012 Mar 1;366(9):787-98
pubmed: 22375970
Nature. 2020 Oct;586(7830):578-582
pubmed: 32731258
N Engl J Med. 2020 Oct 15;383(16):1544-1555
pubmed: 32722908
Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1680-4
pubmed: 9817725
Cardiovasc Res. 2020 May 1;116(6):1097-1100
pubmed: 32227090
J Virol. 2002 Mar;76(6):2667-75
pubmed: 11861833
J Am Soc Nephrol. 2011 Jan;22(1):137-45
pubmed: 21148255
Radiology. 2020 Apr;295(1):202-207
pubmed: 32017661
Nat Commun. 2021 Jan 11;12(1):267
pubmed: 33431879
J Virol. 1999 Dec;73(12):10245-53
pubmed: 10559341
Mol Ther. 2021 Jun 2;29(6):1970-1983
pubmed: 33823303
Clin Microbiol Infect. 2021 Jan;27(1):105-111
pubmed: 32971254
Lancet. 2020 Aug 15;396(10249):467-478
pubmed: 32702298
JAMA Intern Med. 2020 Nov 01;180(11):1447-1452
pubmed: 32780793
Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):4040-4047
pubmed: 32329881
Mol Ther Nucleic Acids. 2019 Apr 15;15:1-11
pubmed: 30785039
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Nature. 2020 Oct;586(7830):567-571
pubmed: 32756549
Trends Pharmacol Sci. 2014 Aug;35(8):414-22
pubmed: 24975478
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
EClinicalMedicine. 2020 Aug;25:100484
pubmed: 32838240
N Engl J Med. 2020 Nov 12;383(20):1920-1931
pubmed: 32663912
Nat Med. 2020 Jun;26(6):842-844
pubmed: 32398875
Acute Med Surg. 2019 Apr 25;6(4):329-335
pubmed: 31592318
J Am Soc Nephrol. 2012 Jul;23(7):1155-60
pubmed: 22626820
Eur J Pharmacol. 2020 Dec 15;889:173556
pubmed: 32941927
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Lancet. 2016 May 7;387(10031):1921-7
pubmed: 26952547
PLoS Med. 2020 Sep 22;17(9):e1003346
pubmed: 32960881
Ann Intern Med. 2020 Oct 20;173(8):623-631
pubmed: 32673060
J Nephrol. 2020 Dec;33(6):1373-1376
pubmed: 32981025
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
N Engl J Med. 2003 May 15;348(20):1986-94
pubmed: 12682352
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Front Immunol. 2020 Aug 14;11:2072
pubmed: 32922409
Oncologist. 2018 Aug;23(8):943-947
pubmed: 29622697
Leukemia. 2020 Jul;34(7):1805-1815
pubmed: 32518419
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Front Public Health. 2020 Jul 03;8:355
pubmed: 32719766
Clin Infect Dis. 2020 Jul 28;71(15):713-720
pubmed: 32129843
Signal Transduct Target Ther. 2020 Apr 28;5(1):57
pubmed: 32341331
J Rheumatol. 2013 Apr;40(4):369-78
pubmed: 23378467
Nat Commun. 2020 Nov 13;11(1):5761
pubmed: 33188185
JAMA. 1967 Dec 18;202(12):1075-80
pubmed: 6072745
Cell. 2020 May 28;181(5):1016-1035.e19
pubmed: 32413319
RNA Biol. 2012 Nov;9(11):1319-30
pubmed: 23064118
Cell Discov. 2020 Mar 18;6:16
pubmed: 32194981
Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7025-8
pubmed: 11416182
J Biol Chem. 2002 Apr 26;277(17):14838-43
pubmed: 11815627
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Science. 2020 Aug 21;369(6506):1014-1018
pubmed: 32540904
Clin Infect Dis. 2021 Jun 1;72(11):e742-e749
pubmed: 32964913
Science. 1990 Mar 23;247(4949 Pt 1):1465-8
pubmed: 1690918
Biotechnol Bioeng. 2021 Feb;118(2):1013-1021
pubmed: 33128388
Clin Rev Allergy Immunol. 2012 Apr;42(2):145-53
pubmed: 21221847
Nature. 2020 Oct;586(7830):589-593
pubmed: 32785213
Viruses. 2019 Apr 04;11(4):
pubmed: 30987343
Nature. 2020 May;581(7807):221-224
pubmed: 32225175
J Med Virol. 2021 Feb;93(2):582-584
pubmed: 32776556
Cell Rep Med. 2020 Oct 29;1(8):100137
pubmed: 33294858
N Engl J Med. 2007 Sep 13;357(11):1162-3
pubmed: 17855683
Lancet. 2020 Aug 15;396(10249):479-488
pubmed: 32702299
N Engl J Med. 2006 Sep 21;355(12):1233-43
pubmed: 16990386
Laryngoscope. 2020 Jul;130(7):1787
pubmed: 32237238
Nucleic Acids Res. 2011 Nov;39(21):e142
pubmed: 21890902
N Engl J Med. 2020 Aug 20;383(8):789-790
pubmed: 32530585
Science. 2020 Nov 27;370(6520):1110-1115
pubmed: 33037066
Mol Cancer Ther. 2012 Aug;11(8):1623-6
pubmed: 22638145
Circ Res. 2000 Sep 1;87(5):E1-9
pubmed: 10969042
Nature. 2005 Jul 7;436(7047):112-6
pubmed: 16001071
Epidemiol Infect. 2020 Jul 09;148:e139
pubmed: 32641174
N Engl J Med. 2020 Dec 10;383(24):2333-2344
pubmed: 33085857
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734
pubmed: 32376634
Virol J. 2005 Aug 22;2:69
pubmed: 16115318
N Engl J Med. 2020 Dec 10;383(24):2320-2332
pubmed: 32877576
N Engl J Med. 2020 Dec 17;383(25):2427-2438
pubmed: 32991794
J Exp Med. 2018 Jun 4;215(6):1571-1588
pubmed: 29739835
Nature. 2020 Oct;586(7830):583-588
pubmed: 32731257
Nat Commun. 2020 May 20;11(1):2601
pubmed: 32433465
J Med Virol. 2020 Oct;92(10):1890-1901
pubmed: 32293713
Nat Rev Immunol. 2010 Jun;10(6):387-402
pubmed: 20467426
JAMA. 2020 Apr 21;323(15):1488-1494
pubmed: 32125362
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975
pubmed: 32350134
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496
pubmed: 32253318
Nat Commun. 2020 Aug 14;11(1):4081
pubmed: 32796842
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
Am J Epidemiol. 1969 Apr;89(4):422-34
pubmed: 4305198
N Engl J Med. 2020 Jun 18;382(25):2411-2418
pubmed: 32379955
Science. 2020 Jun 26;368(6498):1499-1504
pubmed: 32358203
MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1522-1527
pubmed: 33090978
Signal Transduct Target Ther. 2020 Dec 4;5(1):283
pubmed: 33277466
Nat Commun. 2020 Jul 9;11(1):3523
pubmed: 32647131
Ann Rheum Dis. 2010 Jan;69(1):20-8
pubmed: 19103632
Transl Res. 2020 Jun;220:1-13
pubmed: 32299776
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
Nat Med. 2005 Aug;11(8):875-9
pubmed: 16007097
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Chest. 2020 Oct;158(4):1397-1408
pubmed: 32553536
Cell Rep. 2020 Jul 21;32(3):107940
pubmed: 32668216
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
Clin Immunol. 2020 Oct;219:108555
pubmed: 32771488
Clin Immunol. 2020 Nov;220:108598
pubmed: 32961333
Lancet. 2015 Sep 5;386(9997):995-1007
pubmed: 26049252
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Radiology. 2020 Apr;295(1):210-217
pubmed: 32027573
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3
pubmed: 32320677
PLoS Pathog. 2021 May 20;17(5):e1009576
pubmed: 34015061
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346
pubmed: 32214079
Am J Respir Crit Care Med. 2018 Mar 15;197(6):757-767
pubmed: 29161116
Nat Med. 2020 May;26(5):681-687
pubmed: 32327758
JAMA. 2018 Apr 10;319(14):1431-1432
pubmed: 29566112
N Engl J Med. 2020 Dec 17;383(25):2439-2450
pubmed: 33053279
Cell. 2020 May 14;181(4):894-904.e9
pubmed: 32275855
Lancet Respir Med. 2020 Sep;8(9):853-862
pubmed: 32735842
J Intern Med. 2008 Apr;263(4):432-9
pubmed: 18298483

Auteurs

Vladislav Izda (V)

Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Program, Oklahoma City, OK, United States of America.

Matlock A Jeffries (MA)

Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Program, Oklahoma City, OK, United States of America; University of Oklahoma Health Sciences Center, Department of Internal Medicine, Division of Rheumatology, Immunology, and Allergy, Oklahoma City, OK, United States of America. Electronic address: Matlock-Jeffries@omrf.org.

Amr H Sawalha (AH)

University of Pittsburgh, Departments of Pediatrics, Medicine, and Immunology, and Lupus Center of Excellence, Pittsburgh, PA, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH